[go: up one dir, main page]

CU22823A1 - PROCEDURE FOR OBTAINING A LIVING VACCINE FROM VIRUELA AVIAR - Google Patents

PROCEDURE FOR OBTAINING A LIVING VACCINE FROM VIRUELA AVIAR

Info

Publication number
CU22823A1
CU22823A1 CU1998181A CU1998181A CU22823A1 CU 22823 A1 CU22823 A1 CU 22823A1 CU 1998181 A CU1998181 A CU 1998181A CU 1998181 A CU1998181 A CU 1998181A CU 22823 A1 CU22823 A1 CU 22823A1
Authority
CU
Cuba
Prior art keywords
procedure
viruela
aviar
obtaining
living vaccine
Prior art date
Application number
CU1998181A
Other languages
Spanish (es)
Inventor
Portal Sandra Cuello
Drake Amalia Nunez
Zamora Pastor Alfonso
Gonzalez Carmen Laura Perera
Gonzalez Laura I Coroas
Arias Armando R Fernandez
Gomez Julia Noda
Original Assignee
Ct Nac De Sanidad Agropecuaria
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ct Nac De Sanidad Agropecuaria filed Critical Ct Nac De Sanidad Agropecuaria
Priority to CU1998181A priority Critical patent/CU22823A1/en
Publication of CU22823A1 publication Critical patent/CU22823A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Se desarrolla un procedimiento que permite obtener una cepa de viruela aviar adaptada a cultivos de fibroblastos de embrión de pollo, modificada con características biológicas y moleculares que la diferencian de otras cepas vacunales. Se desarrolla a su vez un nuevo método para la extracción del virus intracelular que permite su producción, evaluación y aplicación como cepa vacunal con inocuidad y eficacia para la protección contra la enfermedad.A procedure is developed that allows to obtain an avian smallpox strain adapted to chicken embryo fibroblast cultures, modified with biological and molecular characteristics that differentiate it from other vaccine strains. A new method for the extraction of the intracellular virus that allows its production, evaluation and application as a vaccine strain with safety and efficacy for the protection against the disease is developed.

CU1998181A 1998-12-01 1998-12-01 PROCEDURE FOR OBTAINING A LIVING VACCINE FROM VIRUELA AVIAR CU22823A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU1998181A CU22823A1 (en) 1998-12-01 1998-12-01 PROCEDURE FOR OBTAINING A LIVING VACCINE FROM VIRUELA AVIAR

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU1998181A CU22823A1 (en) 1998-12-01 1998-12-01 PROCEDURE FOR OBTAINING A LIVING VACCINE FROM VIRUELA AVIAR

Publications (1)

Publication Number Publication Date
CU22823A1 true CU22823A1 (en) 2003-01-29

Family

ID=46599423

Family Applications (1)

Application Number Title Priority Date Filing Date
CU1998181A CU22823A1 (en) 1998-12-01 1998-12-01 PROCEDURE FOR OBTAINING A LIVING VACCINE FROM VIRUELA AVIAR

Country Status (1)

Country Link
CU (1) CU22823A1 (en)

Similar Documents

Publication Publication Date Title
MXPA05009580A (en) Influenza virus vaccine.
MX2018010586A (en) STING ACTIVATION NANOVACUNA FOR IMMUNOTHERAPY.
BR112012004806B8 (en) immunogenic compositions that include modulators of tlr activity, method to increase the effectiveness of said composition and use
CY1111552T1 (en) USE OF HPV16 AND HPV18 AS A VACCINE AGAINST ONE OR MORE OVOGENIC HPV TYPE 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
BR112012019176A2 (en) garment, in particular a compression garment for medical purposes.
CR20150291A (en) COMPOSITION INCLUDING A BIOLOGICAL CONTROL AGENT AND AN INSECTICIDE
TNSN07387A1 (en) C.perfringens alpha toxoid vaccine
AR030829A1 (en) A FORMATION OF VACCINE, PROCEDURE FOR THE PRODUCTION OF THE SAME, USE OF SUCH PREPARATION AND A CASE FOR ADMINISTRATION VIA INTRANASAL
DE60330708D1 (en) VACCINE AGAINST WEST NILE VIRUS
CY1115690T1 (en) ARTHROSPIRA BASED COMPOSITIONS AND THEIR USES
MX2023003199A (en) CORONAVIRUS DISEASE 2019 (COVID-19) VACCINE BASED ON PARAINFLUENZA VIRUS 5 (PIV5).
CL2020000491A1 (en) Methods to increase and / or stabilize cardiac function in patients with Fabry disease.
MX2020003591A (en) Recombinant non-pathogenic marek's disease virus constructs encoding multiple heterologous antigens.
AR047581A1 (en) CALCIVIRUS FELINO VACCINES
BR0209145A (en) Smallpox vaccine
CU22823A1 (en) PROCEDURE FOR OBTAINING A LIVING VACCINE FROM VIRUELA AVIAR
MX2021000601A (en) Methods of treating hfpef employing dapagliflozin and compositions comprising the same.
AR124522A1 (en) LIVING RECOMBINANT IMMUNOGENIC COMPOSITION COMPRISING THE NEWCASTLE DISEASE VIRUS (NDV) EXPRESSING THE S1 SUBUNIT AND RBD OF THE SARS-CoV-2 SPIKE PROTEIN
MY153290A (en) Multivalent avian influenza vaccines
BR112018074277A2 (en) arthrogenic alphavirus vaccine
BRPI0516314A (en) use of whole hiv and method of treatment of a chronically infected individual with hiv
PE20150323A1 (en) MODIFIED MAREK DISEASE VIRUS AND VACCINES MADE WITH THE
AR048671A1 (en) VACCINATION PROCEDURE AGAINST TESTICULAR INFECTION BY BVDV
BRPI0512042B8 (en) immunogenic composition, vaccine, use of a composition or vaccine, method for producing an immunogenic composition, and, use of vlps or capsomeres of hpv 16 and 18 with vlps or capsomeres of at least one other hpv of the cancer-causing type
MX2023007375A (en) Modified parapoxvirus having increased immunogenicity.